Pharmabiz

Cellectis doses first patient with BPDCN in phase I study of UCART123

Cellectis doses first patient with BPDCN in phase I study of UCART123: New York Saturday, August 19, 2017, 18:00 Hrs [IST] Cellectis, a clinical-stage biopharmaceutical company fo ...
Pharmabiz

Quotient Sciences initiates AI-designed drug product to guide formulation design and accelerate drug development

Quotient Sciences has announced the successful initiation of a clinical study evaluating a novel drug product developed using artificial intelligence (AI) - a landmark achievement highlighting the ...
Pharmabiz

Altimmune announces IMPACT phase 2b data from pemvidutide; shows significant metabolic improvements in patients with MASH

Altimmune announces IMPACT phase 2b data from pemvidutide; shows significant metabolic improvements in patients with MASH: Gaithersburg, Maryland Saturday, May 30, 2026, 16:00 Hrs ...
Pharmabiz

US FDA grants Orphan Drug Designation to RenovoRx’s oxaliplatin for the treatment of pancreatic cancer

US FDA grants Orphan Drug Designation to RenovoRx’s oxaliplatin for the treatment of pancreatic cancer: Mountain View, California Saturday, May 30, 2026, 17:00 Hrs [IST] RenovoR ...
Pharmabiz

Labcorp introduces expanded DPYD test to identify cancer patients at risk for severe chemotherapy side effects

Labcorp introduces expanded DPYD test to identify cancer patients at risk for severe chemotherapy side effects: Burlington, North Carolina Saturday, May 30, 2026, 15:00 Hrs [IST] ...
Pharmabiz

US FDA approves AstraZeneca’s Imfinzi for patients with BCG-naïve, high-risk non-muscle-invasive bladder cancer

US FDA approves AstraZeneca’s Imfinzi for patients with BCG-naïve, high-risk non-muscle-invasive bladder cancer: Cambridge, UK Saturday, May 30, 2026, 13:00 Hrs [IST] AstraZene ...
Pharmabiz

Dental Commission pushes for practical evaluation model to strengthen real-world training to assess clinical readiness

Dental Commission pushes for practical evaluation model to strengthen real-world training to assess clinical readiness: Nandita Vijayasimha, Bengaluru Saturday, May 30, 2026, 08:0 ...
Pharmabiz

Merz Therapeutics presents new research at WPC 2026, revealing the hidden burden of “OFF” episodes in Parkinson’s disease

Merz Therapeutics, a leading player in neurology-focused specialty pharma, announced the presentation of new research at the World Parkinson Congress (WPC) 2026 that uncovers the multifaceted burden ...
Pharmabiz

Pfizer and Innovent Biologics ink strategic collaboration to accelerate development of innovative oncology medicines

Pfizer and Innovent Biologics ink strategic collaboration to accelerate development of innovative oncology medicines: New York Saturday, May 30, 2026, 09:00 Hrs [IST] Pfizer Inc.
Pharmabiz

Study from Florida Cancer Specialists & Research Institute finds comparable quality & safety outcomes in CAR T-cell therapy; highlights care location as key driver of patient ...

Study from Florida Cancer Specialists & Research Institute finds comparable quality & safety outcomes in CAR T-cell therapy; highlights care location as key driver of patient acce ...
Opinion
PharmabizOpinion

India needs stronger standardisation in nutraceuticals without which expansion is difficult: Suresh Garg

India needs stronger standardisation in nutraceuticals without which expansion is difficult: Suresh Garg: Nandita Vijayasimha, Bengaluru Saturday, May 30, 2026, 08:00 Hrs [IST] In ...
Pharmabiz

WHO issues first recommendation on doxycycline post-exposure prophylaxis to help prevent sexually transmitted infections

WHO issues first recommendation on doxycycline post-exposure prophylaxis to help prevent sexually transmitted infections: Geneva Saturday, May 30, 2026, 10:00 Hrs [IST] The World ...